Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy West Pharmaceutical Services stock

Learn how to easily invest in West Pharmaceutical Services stock.

West Pharmaceutical Services Inc is a medical instruments & supplies business based in the US. West Pharmaceutical Services shares (WST) are listed on the NYSE and all prices are listed in US Dollars. West Pharmaceutical Services employs 10,065 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in West Pharmaceutical Services

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – WST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

West Pharmaceutical Services stock price (NYSE: WST)

Use our graph to track the performance of WST stocks over time.

West Pharmaceutical Services shares at a glance

Information last updated 2022-06-24.
Latest market close$302.37
52-week range$275.89 - $474.69
50-day moving average $315.86
200-day moving average $390.55
Wall St. target price$386.20
PE ratio 33.3296
Dividend yield $0.7 (0.25%)
Earnings per share (TTM) $8.97

Buy West Pharmaceutical Services shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy West Pharmaceutical Services stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

West Pharmaceutical Services price performance over time

Historical closes compared with the close of $302.37 from 2022-06-30

1 week (2022-06-24) 0.40%
1 month (2022-06-01) -2.01%
3 months (2022-03-31) -26.38%
6 months (2021-12-28) N/A
1 year (2021-07-01) -16.70%
2 years (2020-07-01) 34.39%
3 years (2019-07-01) 142.42%
5 years (2017-06-30) 219.90%

Is West Pharmaceutical Services stock undervalued or overvalued?

Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

West Pharmaceutical Services's P/E ratio

West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, West Pharmaceutical Services shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

West Pharmaceutical Services's PEG ratio

West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0503. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

West Pharmaceutical Services's EBITDA

West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $895.6 million.

The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.

West Pharmaceutical Services financials

Revenue TTM $2.9 billion
Operating margin TTM 26.83%
Gross profit TTM $1.2 billion
Return on assets TTM 16.01%
Return on equity TTM 32.94%
Profit margin 23.76%
Book value $31.39
Market capitalisation $22.1 billion

TTM: trailing 12 months

West Pharmaceutical Services share dividends

8%

Dividend payout ratio: 8.13% of net profits

Recently West Pharmaceutical Services has paid out, on average, around 8.13% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.25% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0.25% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.7 per share.

While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.

West Pharmaceutical Services's most recent dividend payout was on 2 August 2022. The latest dividend was paid out to all shareholders who bought their shares by 18 July 2022 (the "ex-dividend date").

Have West Pharmaceutical Services's shares ever split?

West Pharmaceutical Services's shares were split on a 2:1 basis on 26 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for West Pharmaceutical Services shares which in turn could have impacted West Pharmaceutical Services's share price.

West Pharmaceutical Services share price volatility

Over the last 12 months, West Pharmaceutical Services's shares have ranged in value from as little as $275.89 up to $474.6883. A popular way to gauge a stock's volatility is its "beta".

WST.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 1.1751. This would suggest that West Pharmaceutical Services's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

West Pharmaceutical Services overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Frequently asked questions

What percentage of West Pharmaceutical Services is owned by insiders or institutions?
Currently 0.623% of West Pharmaceutical Services shares are held by insiders and 97.864% by institutions.
How many people work for West Pharmaceutical Services?
Latest data suggests 10,065 work at West Pharmaceutical Services.
When does the fiscal year end for West Pharmaceutical Services?
West Pharmaceutical Services's fiscal year ends in December.
Where is West Pharmaceutical Services based?
West Pharmaceutical Services's address is: 530 Herman O. West Drive, Exton, PA, United States, 19341-0645
What is West Pharmaceutical Services's ISIN number?
West Pharmaceutical Services's international securities identification number is: US9553061055
What is West Pharmaceutical Services's CUSIP number?
West Pharmaceutical Services's Committee on Uniform Securities Identification Procedures number is: 953348109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site